Femoral Artery News and Research RSS Feed - Femoral Artery News and Research

Regional anesthesia technique allows majority of patients to go home within hours of surgery

Regional anesthesia technique allows majority of patients to go home within hours of surgery

A recent study of an ultrasound-guided regional anesthesia technique, called femoral nerve block, shows that it leads to less opioid use and allows the majority of patients to go home within hours of surgery. [More]
Incisionless TAVR surgery cuts length of hospital stay by 30%

Incisionless TAVR surgery cuts length of hospital stay by 30%

New research from Penn Medicine shows that incisionless transcatheter aortic valve replacement (TAVR) surgery cuts length of hospital stay by 30 percent and has no impact on post-operative vascular complication rates when compared with conventional transfemoral TAVR, which requires an incision in the groin. [More]
Drug-eluting peripheral stent from Cook Medical selected as a top 10 game-changing health technology for 2014

Drug-eluting peripheral stent from Cook Medical selected as a top 10 game-changing health technology for 2014

As announced at the 2014 Canadian Agency for Drugs and Technologies in Health (CADTH) symposium, the Canadian Network for Environmental Scanning in Health (CNESH) has selected Cook Medical’s Zilver® PTX® drug-eluting peripheral stent as a top 10 game-changing health technology for 2014. The CNESH top 10 list is designed to encourage the adoption and use of effective, safe health technologies in Canada. [More]
Radial artery catheterization much safer for women

Radial artery catheterization much safer for women

Instead of going through the groin during heart catheterizations, physicians can now insert the catheter through a patient's wrist, a less traumatic and safer option for some patients — especially women. [More]
Men advised to take proactive approach to prevent hernia

Men advised to take proactive approach to prevent hernia

As the preeminent hernia specialist in the Western United States, Dr. Shirin Towfigh has diagnosed and treated a number of patients through incisional hernia surgery and other cutting-edge techniques. [More]
Cook Medical introduces Zilver PTX Drug-Eluting Peripheral Stent in Canada

Cook Medical introduces Zilver PTX Drug-Eluting Peripheral Stent in Canada

Cook Medical launched its Zilver PTX Drug-Eluting Peripheral Stent in Canada at the Canadian Interventional Radiology Association (CIRA) meeting in Montreal, Canada. It's the first drug-coated stent in Canada indicated to treat peripheral arterial disease (PAD) in the superficial femoral artery (SFA). [More]
Zilver® PTX® drug-eluting stent from Cook Medical receives positive one-year follow-up results

Zilver® PTX® drug-eluting stent from Cook Medical receives positive one-year follow-up results

One-year follow-up data from 907 Japanese patients who received the Zilver® PTX® drug-eluting stent showed positive results in keeping open the superficial femoral artery (SFA). The postmarket surveillance (PMS) study, designed to evaluate the stent’s performance in real-world patient use, was presented at the 2014 Euro PCR meeting. [More]
RWJUH offers new alternative to open up blocked arteries

RWJUH offers new alternative to open up blocked arteries

Treatment options for high-risk heart patients with severely calcified coronary artery disease (CAD) have been limited for more than 20 years. Now, Robert Wood Johnson University Hospital offers a new alternative to open up blocked arteries. [More]
Cardinal Health agrees to acquire AccessClosure for $320 million

Cardinal Health agrees to acquire AccessClosure for $320 million

Cardinal Health today announced an agreement to acquire privately held AccessClosure Inc., a leading manufacturer and distributor of extravascular closure devices in the United States, for $320 million. Subject to customary closing conditions and regulatory clearances, the all-cash transaction is expected to close by early June 2014. [More]
Mechanical circulatory assist device may have untapped potential in heart surgery patients, say physicians

Mechanical circulatory assist device may have untapped potential in heart surgery patients, say physicians

The most frequently used mechanical circulatory assist device in the world may have untapped potential, physicians say. [More]
AccessClosure commercially launches Mynx Ace Vascular Closure Device

AccessClosure commercially launches Mynx Ace Vascular Closure Device

AccessClosure Inc., the market leader in extravascular care technology, has commercially launched its Mynx Ace Vascular Closure Device, a safe and secure vascular closure product that provides consistent results with a new, easy-to-use deployment system to seal femoral artery access sites. [More]
CSI's new Diamondback Peripheral 60cm systems receive FDA clearance for PAD treatment

CSI's new Diamondback Peripheral 60cm systems receive FDA clearance for PAD treatment

Cardiovascular Systems, Inc., announced today it has received FDA clearance of its new Diamondback 360 60cm Peripheral Orbital Atherectomy Systems (OAS) for the treatment of peripheral arterial disease (PAD). [More]
Report highlights benefits of different access approach to treat uterine fibroids

Report highlights benefits of different access approach to treat uterine fibroids

Interventional radiologists have devised a new way to access a woman's fibroids-by flipping her wrist and treating via an arm not groin artery-to nonsurgically shrink noncancerous growths in the muscular wall of the uterus. Researchers found this to be less painful and traumatic for women, allowing them to immediately sit up and move after uterine fibroid embolization (UFE)-with no overnight stay, according to a March article in the Society of Interventional Radiology's flagship publication, the Journal of Vascular and Interventional Radiology. [More]
Loyola surgeon successfully performs operation on patient suffering from rare disorder

Loyola surgeon successfully performs operation on patient suffering from rare disorder

Jarely Sanchez is an affectionate, energetic little girl who loves ballet. "Everyone she meets, she connects with," said her father, Jose Angel Ulloa. "She's like a magnet." But for more than a week, the three-year-old girl wasn't herself. [More]
Zilver PTX randomized trial of paclitaxel-eluting stents for femoropopliteal disease demonstrates superior results

Zilver PTX randomized trial of paclitaxel-eluting stents for femoropopliteal disease demonstrates superior results

Four-year results of the Zilver PTX Randomized Controlled Trial of Paclitaxel-Eluting Stents for Femoropopliteal Disease continue to demonstrate consistent, superior results when compared to bare metal stents (BMS) and percutaneous transluminal angioplasty (PTA) in terms of primary patency, restenosis reduction and revascularization rates. [More]
BIDMC receives FDA approval to use new medical device in patients with severely damaged aortic heart valves

BIDMC receives FDA approval to use new medical device in patients with severely damaged aortic heart valves

Beth Israel Deaconess Medical Center (BIDMC) yesterday became the first institution in the United States to use a new minimally invasive medical device since it received FDA approval last week. [More]
FDA grants indication for GORE VIABAHN Endoprosthesis to treat thrombotic occlusion

FDA grants indication for GORE VIABAHN Endoprosthesis to treat thrombotic occlusion

W. L. Gore & Associates today announced that the Food and Drug Administration has granted indication for the GORE VIABAHN Endoprosthesis to treat stenosis or thrombotic occlusion at the venous anastomosis of synthetic arteriovenous access grafts. [More]
New strategy for emergency anticoagulant treatment for patients with myocardial infarction

New strategy for emergency anticoagulant treatment for patients with myocardial infarction

A new strategy for emergency anticoagulant treatment for patients with acute myocardial infarction has been put in place by a team led by Philippe-Gabriel Steg at Inserm Unit 698 (Haemostasis, Bioengineering, Immunopathology and Cardiovascular Remodelling), at H-pital Bichat, AP-HP, Universit- Paris Diderot). [More]
Wrist artery for coronary angioplasty may benefit women at high risk of blood loss

Wrist artery for coronary angioplasty may benefit women at high risk of blood loss

For women who are at high risk of blood loss, using an artery in the wrist may be better than the groin for routing a stent to the heart during coronary angioplasty, according to researchers at Duke Medicine. [More]
Auckland physician performs first patient implant of Boston Scientific Innova DES System

Auckland physician performs first patient implant of Boston Scientific Innova DES System

Launching a key clinical trial expected to serve as the foundation for global regulatory approvals, a physician in Auckland, New Zealand has performed the first patient implant of the Boston Scientific Corporation Innova Drug-Eluting Stent System. [More]